| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/06/2013 | WO2013109213A3 Pharmaceutical formulations comprising tiotropium |
| 09/06/2013 | WO2013078564A3 Targeted lysosomal enzyme compounds |
| 09/06/2013 | WO2013078562A3 Targeted iduronate-2-sulfatase compounds |
| 09/06/2013 | WO2013014677A8 Matrix compositions for controlled release of peptide and polypeptide molecules |
| 09/06/2013 | WO2012024260A3 Intranasal delivery of cell permeant therapeutics |
| 09/06/2013 | CA2852042A1 Tamper resistant immediate release formulations |
| 09/05/2013 | US20130231881 System and Method for Monitoring Power Source Longevity of an Implantable Medical Device |
| 09/05/2013 | US20130231529 Devices, systems and methods for diagnosing and treating sinusitis andother disorders of the ears, nose and/or throat |
| 09/05/2013 | US20130231490 Method for preparing water-soluble polymer derivatives bearing an n-succinimidyl ester |
| 09/05/2013 | US20130231318 Ocular implant made by a double extrusion process |
| 09/05/2013 | US20130231317 Dhea bioadhesive controlled release gel |
| 09/05/2013 | US20130231311 Novel formulations for treatment of migraine |
| 09/05/2013 | US20130231310 Mesalamine suppository |
| 09/05/2013 | US20130231285 Methods for Treating Skin Aging and Scars |
| 09/05/2013 | US20130230599 Spray Dried Human Plasma |
| 09/05/2013 | US20130230598 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid |
| 09/05/2013 | US20130230597 Enteric-coated sodium metabisulfite livestock feed additive for vomitoxin detoxification |
| 09/05/2013 | US20130230596 Abuse-Resistant Oral Dosage Forms And Method Of Use Thereof |
| 09/05/2013 | US20130230593 Orally Dosed Pharmaceutical Compositions Comprising a Delivery Agent in Micronized Form |
| 09/05/2013 | US20130230590 Pharmaceutical composition comprising bicarbonate salt, and use thereof as a medicament in the treatment and/or prevention of urinary lithiases and related diseases |
| 09/05/2013 | US20130230589 Pharmaceutical formulations useful in the treatment of insomnia |
| 09/05/2013 | US20130230588 Controlled release compositions |
| 09/05/2013 | US20130230587 Sustained release compositions |
| 09/05/2013 | US20130230586 Treatment of Tinnitus and Related Auditory Dysfunctions |
| 09/05/2013 | US20130230583 Modified drugs for use in liposomal nanoparticles |
| 09/05/2013 | US20130230582 Modified drugs for use in liposomal nanoparticles |
| 09/05/2013 | US20130230576 Microlayer coextrusion to create a time-release drug |
| 09/05/2013 | US20130230570 Hollow silica nanospheres and methods of making same |
| 09/05/2013 | US20130230567 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same |
| 09/05/2013 | US20130230489 Paediatric Compositions For Treating Multiple Sclerosis |
| 09/05/2013 | US20130230457 Thermosensitive Nanoparticle Formulations and Method of Making The Same |
| 09/04/2013 | EP2634179A1 Functional PLA-PEG copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging |
| 09/04/2013 | EP2634177A1 Tau imaging probe |
| 09/04/2013 | EP2633879A1 Micro-needle coating method |
| 09/04/2013 | EP2633862A1 Compositions based on propolis nanocapsules which can be used as carriers for substances of interest, methods for producing same and use thereof |
| 09/04/2013 | EP2633857A1 Solid pharmaceutical dosage form of ticagrelor and acetylsalicylic acid |
| 09/04/2013 | EP2633853A1 Long-term delivery formulations and methods of use thereof |
| 09/04/2013 | EP2633852A1 Jojoba oil-containing ophthalmic spray composition |
| 09/04/2013 | EP2633765A1 Instant compositions comprising polydextrose, the production and use thereof |
| 09/04/2013 | EP2633763A1 A particulate flavour delivery system, a method of making it and use thereof |
| 09/04/2013 | EP2633318A1 Coated beads |
| 09/04/2013 | EP2632553A1 A sustained release formulation of a non-steroidal anti-inflammatory drug |
| 09/04/2013 | EP2632447A1 A process for preparing curcumin encapsulated chitosan alginate sponge useful for wound healing |
| 09/04/2013 | EP2632443A2 Preparation of orodispersible films |
| 09/04/2013 | EP2632442A2 Formulations and methods for attenuating respiratory depression induced by opioid overdose |
| 09/04/2013 | EP2632441A2 Compositions of (-)-17-(cyclobutylmethyl) morphinan-3, 14-diol |
| 09/04/2013 | EP2632440A2 Process for analyzing and establishing dosage size in an ingestible film |
| 09/04/2013 | EP2632439A1 Pharmaceutical formulations of a substituted diaminopurine |
| 09/04/2013 | EP2632438A1 Multilayer pharmaceutical composition comprising telmisartan and amlodipine |
| 09/04/2013 | EP2632437A2 Ternary mixture formulations |
| 09/04/2013 | EP2632436A1 Solid dispersions containing an apoptosis-inducing agent |
| 09/04/2013 | EP2632435A1 Liposomal drug composition containing a polymeric guanidine derivative |
| 09/04/2013 | EP2632434A1 Liposome-based construct comprising a peptide modified through hydrophobic moieties |
| 09/04/2013 | EP2632433A2 Liquid formulations of long acting interferon alpha conjugate |
| 09/04/2013 | EP2632432A2 Composition and method for treating wounds |
| 09/04/2013 | EP2632431A1 Inflammatory disease |
| 09/04/2013 | EP2632430A1 Nasal compositions of vitamin b12 |
| 09/04/2013 | EP2632429A1 Oral pharmaceutical film formulation for bitter-tasting drugs |
| 09/04/2013 | EP2632428A1 Modified starch derivative-based matrix for colon targeting |
| 09/04/2013 | EP2632427A1 Ophthalmic composition |
| 09/04/2013 | EP1997478B1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| 09/04/2013 | DE202012101982U1 Lactasetablette und Lactasetablette mit Spender Lactasetablette and Lactasetablette with donor |
| 09/04/2013 | CN203169621U Medical medicament sticker |
| 09/04/2013 | CN1856299B 口服药物释出系统 Oral drug release system |
| 09/04/2013 | CN1774238B Formulations and methods for treating rhinosinusitis |
| 09/04/2013 | CN1578670B Use of lactalapoprotein in prevention and treatment of microbial or virus infection |
| 09/04/2013 | CN103282458A Composition for adhesive hydrogel and use thereof |
| 09/04/2013 | CN103282380A Erythrocyte-binding therapeutics |
| 09/04/2013 | CN103282053A Medical device for controlled release of drug |
| 09/04/2013 | CN103282052A Aqueous ophthalmic composition |
| 09/04/2013 | CN103282051A Orally disintegrating tablet |
| 09/04/2013 | CN103282043A Lissencephaly therapeutic agent |
| 09/04/2013 | CN103282042A Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph |
| 09/04/2013 | CN103282039A Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate |
| 09/04/2013 | CN103282038A Phosphomycin pharmaceutical composition |
| 09/04/2013 | CN103282036A Compositions and methods for treating myelofibrosis |
| 09/04/2013 | CN103282033A Compounds and methods for skin repair |
| 09/04/2013 | CN103282028A Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria |
| 09/04/2013 | CN103282027A Pharmaceutical composite formulation comprising hmg-oa reductase inhibitor and aspirin |
| 09/04/2013 | CN103282026A Dosage form |
| 09/04/2013 | CN103282025A Melt-extruded solid dispersions containing an apoptosis-nducing agent |
| 09/04/2013 | CN103282024A Compositions and methods for nanopolymer-ased nucleic acid delivery |
| 09/04/2013 | CN103282023A Rabies glycoprotein virus-ike particles (vlps) |
| 09/04/2013 | CN103282022A Pharmaceutical compositions |
| 09/04/2013 | CN103282021A 炎症性疾病 Inflammatory diseases |
| 09/04/2013 | CN103282020A Bioerodible silicon-ased devices for delivery of therapeutic agents |
| 09/04/2013 | CN103282015A Dissolvable fibrous web structure article comprising active agents |
| 09/04/2013 | CN103275901A Space-induced efficient bacillus natto, application of bacillus natto and preparation method of troche of bacillus natto |
| 09/04/2013 | CN103275178A Preparation of n-dodecanoic acid-RGD (arginine-glycine-aspartic acid)-n-tetradecanol mediated fanny targeted liposome, and evaluation of anti-tumor activity |
| 09/04/2013 | CN103275159A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 09/04/2013 | CN103275154A Preparation method of crystalline particles of acetyl isovaleryl tylosin salt |
| 09/04/2013 | CN103275058A Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 09/04/2013 | CN103273080A Nanometer golden flower and preparation method and application of nanometer golden flower |
| 09/04/2013 | CN103272243A Pharmaceutical compositions having a modified vehicle |
| 09/04/2013 | CN103272237A Waterless reverse micelles nanoparticles of water-soluble drug, and preparation method of suspension aerosol thereof |
| 09/04/2013 | CN103272231A Vaccine for immunizing sheep for producing twins and preparation method thereof |
| 09/04/2013 | CN103272224A Lysozyme sugar lozenge and preparation method thereof |
| 09/04/2013 | CN103272223A Oxidation prevention health care capsule and preparation method thereof |
| 09/04/2013 | CN103272220A Buserelin acetate lipid microbubble and preparation method thereof |
| 09/04/2013 | CN103272209A Medicine for curing dysmenorrhea |